JP2010533001A5 - - Google Patents

Download PDF

Info

Publication number
JP2010533001A5
JP2010533001A5 JP2010516334A JP2010516334A JP2010533001A5 JP 2010533001 A5 JP2010533001 A5 JP 2010533001A5 JP 2010516334 A JP2010516334 A JP 2010516334A JP 2010516334 A JP2010516334 A JP 2010516334A JP 2010533001 A5 JP2010533001 A5 JP 2010533001A5
Authority
JP
Japan
Prior art keywords
vlp
plant
composition
influenza virus
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010516334A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010533001A (ja
JP5624465B2 (ja
Filing date
Publication date
Priority claimed from CA002615372A external-priority patent/CA2615372A1/en
Application filed filed Critical
Publication of JP2010533001A publication Critical patent/JP2010533001A/ja
Publication of JP2010533001A5 publication Critical patent/JP2010533001A5/ja
Application granted granted Critical
Publication of JP5624465B2 publication Critical patent/JP5624465B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010516334A 2007-07-13 2008-07-11 植物内で生成されるヘマグルチニンを含むインフルエンザウイルス様粒子（ｖｌｐ） Active JP5624465B2 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US95941407P 2007-07-13 2007-07-13
US60/959,414 2007-07-13
US99060307P 2007-11-27 2007-11-27
US60/990,603 2007-11-27
US1327207P 2007-12-12 2007-12-12
US61/013,272 2007-12-12
CA2,615,372 2008-01-21
CA002615372A CA2615372A1 (en) 2007-07-13 2008-01-21 Influenza virus-like particles (vlps) comprising hemagglutinin
US2277508P 2008-01-22 2008-01-22
US61/022,775 2008-01-22
PCT/CA2008/001281 WO2009009876A1 (en) 2007-07-13 2008-07-11 Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant

Publications (3)

Publication Number Publication Date
JP2010533001A JP2010533001A (ja) 2010-10-21
JP2010533001A5 true JP2010533001A5 (enExample) 2013-08-29
JP5624465B2 JP5624465B2 (ja) 2014-11-12

Family

ID=40255124

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010516334A Active JP5624465B2 (ja) 2007-07-13 2008-07-11 植物内で生成されるヘマグルチニンを含むインフルエンザウイルス様粒子（ｖｌｐ）

Country Status (19)

Country Link
US (4) US20100239610A1 (enExample)
EP (1) EP2173886B1 (enExample)
JP (1) JP5624465B2 (enExample)
KR (1) KR101541330B1 (enExample)
CN (1) CN101883856B (enExample)
AU (1) AU2008278222B2 (enExample)
CA (2) CA2615372A1 (enExample)
CR (1) CR11209A (enExample)
DK (1) DK2173886T3 (enExample)
EA (1) EA018206B1 (enExample)
ES (1) ES2428384T3 (enExample)
MX (1) MX2010000525A (enExample)
MY (1) MY155236A (enExample)
NZ (1) NZ582360A (enExample)
PL (1) PL2173886T3 (enExample)
PT (1) PT2173886E (enExample)
SI (1) SI2173886T1 (enExample)
TN (1) TN2009000557A1 (enExample)
WO (1) WO2009009876A1 (enExample)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI377253B (en) 2001-04-16 2012-11-21 Martek Biosciences Corp Product and process for transformation of thraustochytriales microorganisms
US7566458B2 (en) 2003-06-16 2009-07-28 Medimmune, Llc Influenza hemagglutinin and neuraminidase variants
ES2527503T3 (es) 2005-03-08 2015-01-26 Medimmune, Llc Virus influenza reordenantes
EP2044198A4 (en) * 2006-07-27 2010-09-08 Ligocyte Pharmaceuticals Inc CHIMERIC INFLUENZA VIRUS TYPE PARTICLES
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
PT2610345E (pt) 2007-11-27 2016-01-11 Medicago Inc Partículas semelhantes ao vírus (vlps) da gripe recombinantes produzidas em plantas transgénicas que expressam hemaglutinina
EP2294202B1 (en) 2008-07-08 2015-05-20 Medicago Inc. Soluble recombinant influenza antigens
US8591914B2 (en) * 2008-07-11 2013-11-26 Medimmune, Llc Influenza hemagglutinin and neuraminidase variants
CN102165062B (zh) 2008-07-18 2017-09-08 麦迪卡格公司 新的流感病毒免疫表位
AU2015202195B2 (en) * 2008-07-18 2017-10-12 Medicago Inc. New influenza virus immunizing epitope
CN102648207A (zh) 2009-03-16 2012-08-22 马太克生物科学公司 在网粘菌门微生物中产生蛋白质
CA2787099A1 (en) 2009-03-30 2010-10-14 Anice C. Lowen Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof
ES2524541T3 (es) 2009-04-09 2014-12-10 Alfa Biogene International B.V. Filtración de un líquido que comprende una proteína de estrés de plantas
JP5871796B2 (ja) * 2009-06-24 2016-03-01 メディカゴ インコーポレイテッド ヘマグルチニンを含むキメラインフルエンザウイルス様粒子
PL222497B1 (pl) 2009-06-26 2016-08-31 Inst Biochemii I Biofizyki Pan Wektorowa cząsteczka wirusopodobna, sposób jej wytwarzania, kompozycja farmaceutyczna oraz zastosowanie wektorowej cząsteczki wirusopodobnej
WO2011003100A2 (en) 2009-07-02 2011-01-06 Massachusetts Institute Of Technology Compositions and methods for diagnosing and/or treating influenza infection
ES2662778T3 (es) * 2009-09-22 2018-04-09 Medicago Inc. Método de preparación de proteínas derivadas de plantas
EP3505632B1 (en) * 2009-12-28 2022-08-03 Sanofi Vaccine Technologies, S.A.S. Production of heterologous polypeptides in microalgae, microalgal extracellular bodies, compositions, and methods of making and uses thereof
IN2012DN06278A (enExample) 2009-12-28 2015-09-25 Dsm Ip Assets Bv
KR20120101572A (ko) * 2009-12-28 2012-09-13 메리얼 리미티드 재조합 ｎｄｖ 항원 및 이의 용도
US8298820B2 (en) 2010-01-26 2012-10-30 The Trustees Of The University Of Pennsylvania Influenza nucleic acid molecules and vaccines made therefrom
AU2015202267B2 (en) * 2010-01-26 2017-03-23 The Trustees Of The University Of Pennsylvania Influenza nucleic acid molecules and vaccines made therefrom
US9701723B2 (en) 2010-02-18 2017-07-11 Icahn School Of Medicine At Mount Sinai Vaccines for use in the prophylaxis and treatment of influenza virus disease
CN102939103A (zh) 2010-03-30 2013-02-20 西奈山医学院 流感病毒疫苗及其应用
EP2640405A4 (en) 2010-09-21 2015-04-15 Massachusetts Inst Technology HA-POLYPEPTIDES ADAPTED TO HUMANS, VACCINES THEREOF AND INFLUENZA TREATMENT THEREWITH
US20130259928A1 (en) 2010-09-30 2013-10-03 Franvax S.R.L. Generation of virosome particles
SG10201709806VA (en) 2010-10-04 2017-12-28 Massachusetts Inst Technology Hemagglutinin polypeptides, and reagents and methods relating thereto
SG190031A1 (en) * 2010-10-27 2013-06-28 Philip Morris Prod Methods for capturing virus like particles from plants using expanded bed chromatography
JP6025214B2 (ja) * 2010-11-04 2016-11-16 メディカゴ インコーポレイテッド 植物発現系
TWI526539B (zh) * 2010-12-22 2016-03-21 苜蓿股份有限公司 植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp
JP6073247B2 (ja) * 2011-01-17 2017-02-01 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 植物で核酸を発現させるベクター
TWI620816B (zh) * 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法
ES2665512T3 (es) * 2011-06-13 2018-04-26 Medicago Inc. Producción de partículas pseudovíricas de la rabia en plantas
JP6113155B2 (ja) 2011-06-20 2017-04-12 ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 計算で最適化した広い反応性を示すｈ１ｎ１インフルエンザの抗原
KR20140068205A (ko) 2011-09-20 2014-06-05 마운트 시나이 스쿨 오브 메디슨 인플루엔자 바이러스 백신 및 이의 용도
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
CN116218900A (zh) 2011-09-30 2023-06-06 麦迪卡格公司 增加植物中病毒样颗粒的产率
US20140302158A1 (en) * 2011-11-11 2014-10-09 Phillip Morris Products S.A. Influenza virus-like particles (vlps) comprising hemagglutinin produced nicotiana tabacum
US9234008B2 (en) 2012-02-07 2016-01-12 University of Pittsburgh—of the Commonwealth System of Higher Education Computationally optimized broadly reactive antigens for H3N2, H2N2, and B influenza viruses
MY180109A (en) 2012-02-13 2020-11-23 Univ Pittsburgh Commonwealth Sys Higher Education Computationally optimized broadly reactive antigens for human and avian h5n1 influenza
BR112014019755B1 (pt) 2012-03-22 2022-02-22 Fraunhofer Usa, Inc Partícula do tipo viral; método de produção das partículas do tipo viral; composição imunogênica e uso das partículas do tipo viral
CN104284978B (zh) * 2012-05-11 2018-02-02 麦迪卡格公司 植物中类轮状病毒颗粒的产生
ES2911774T3 (es) 2012-09-05 2022-05-20 Medicago Inc Producción de partículas similares a enterovirus 71 en plantas
KR20150104117A (ko) 2012-12-18 2015-09-14 이칸 스쿨 오브 메디슨 엣 마운트 시나이 인플루엔자 바이러스 백신 및 그의 용도
WO2014159960A1 (en) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
EP2978848B1 (en) 2013-03-28 2020-05-06 Medicago Inc. Influenza virus-like particle production in plants
US12467058B2 (en) 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
JP6358257B2 (ja) 2013-09-06 2018-07-18 三菱ケミカル株式会社 植物を用いたタンパク質の製造方法
CA2943796C (en) 2014-03-27 2023-02-14 Medicago Inc. Modified cpmv enhancer elements
US11959088B2 (en) * 2014-07-11 2024-04-16 Aramis Biotechnologies Inc. Modifying protein production in plants
WO2016115630A1 (en) 2015-01-23 2016-07-28 Medicago Inc. Rotavirus-like particle production in plants
US10736956B2 (en) 2015-01-23 2020-08-11 Icahn School Of Medicine At Mount Sinai Influenza virus vaccination regimens
KR101637955B1 (ko) * 2015-05-18 2016-07-08 한국생명공학연구원 범용성 인플루엔자 바이러스 백신 조성물
CN107920487A (zh) 2015-07-02 2018-04-17 莫迪卡戈公司 茉莉酸通路激活剂
WO2017218624A1 (en) 2016-06-15 2017-12-21 Icahn School Of Medicine At Mount Sinai Influenza virus hemagglutinin proteins and uses thereof
WO2018187706A2 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
KR101964044B1 (ko) * 2018-03-14 2019-04-02 인제대학교 산학협력단 재조합 아데노바이러스를 이용한 다가형 인플루엔자 생백신 플랫폼
BR112020018639A2 (pt) 2018-03-14 2020-12-29 Medicago Inc. Potenciador de expressão vegetal
EP3810634A4 (en) 2018-06-21 2022-07-27 Icahn School of Medicine at Mount Sinai Mosaic influenza virus hemagglutinin polypeptides and uses thereof
BR112020026620A8 (pt) * 2018-06-27 2022-01-25 Medicago Inc Mutantes de hemaglutinina do vírus influenza
JP2021528999A (ja) * 2018-07-04 2021-10-28 プロバイオジェン アーゲー エンベロープウイルスの精製方法
WO2020181354A1 (en) 2019-03-14 2020-09-17 Mitsubishi Tanabe Pharma Corporation Endogenous plant expression enhancer
EP3959216A4 (en) 2019-04-24 2023-01-11 Icahn School of Medicine at Mount Sinai ANTI-INFLUENZA B VIRUS NEURAMINIDASE ANTIBODIES AND USES THEREOF
CN114340637A (zh) 2019-07-03 2022-04-12 阿伊里斯株式会社 用于治疗流感病毒感染症的药物组合物
CN111122417B (zh) * 2020-02-22 2022-06-21 太原理工大学 一种测定含瓦斯煤开闭孔总体积膨胀率的装置及方法
CN117479831A (zh) 2021-06-09 2024-01-30 南特知识产权控股有限责任公司 用于在植物中生产感兴趣的蛋白质的方法和系统
CN115992101B (zh) * 2023-03-22 2023-07-28 深圳市卫光生物制品股份有限公司 一种流感病毒裂解疫苗原液的制备方法

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0203177A4 (en) 1984-11-29 1987-04-28 Scripps Clinic Res POLYPEPTIDES AND ANTIBODIES ASSOCIATED WITH VIRAL GLUCOPROTEINS WITHOUT GLUCOSE.
US5232833A (en) * 1988-09-14 1993-08-03 Stressgen Biotechnologies Corporation Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
ATE142883T1 (de) * 1991-03-28 1996-10-15 Rooperol Na Nv Zusammensetzungen von phytosterolen mit phytosterolinen als immunmodulatoren
US6326470B1 (en) 1997-04-15 2001-12-04 The Penn State Research Foundation Enhancement of accessibility of cellulose by expansins
US5762939A (en) * 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
GB9414118D0 (en) 1994-07-13 1994-08-31 Axis Genetics Ltd Modified plant viruses as vectors of heterologous peptides
AU6504796A (en) 1995-07-20 1997-02-18 Washington State University Research Foundation Production of secreted foreign polypeptides in plant cell culture
US6042832A (en) 1996-08-28 2000-03-28 Thomas Jefferson University Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins
US20010006950A1 (en) 1998-02-11 2001-07-05 Juha Punnonen Genetic vaccine vector engineering
US6489537B1 (en) 1998-08-07 2002-12-03 The Trustees Of The University Of Pennsylvania Phytochelatin synthases and uses therefor
KR20010072372A (ko) 1998-08-11 2001-07-31 맥기 데이비드 알 식물조직의 간질액으로부터 단백질을 추출하는 방법
US6392121B1 (en) 1998-10-07 2002-05-21 Boyce Thompson Institute For Plant Research Gemini virus vectors for gene expression in plants
US6287570B1 (en) * 1998-11-23 2001-09-11 Patricia L. Foley Vaccine against swine influenza virus
FR2791358B1 (fr) 1999-03-22 2003-05-16 Meristem Therapeutics Promoteurs chimeriques d'expression, cassettes d'expression, plasmides, vecteurs, plantes et semences transgeniques les contenant et leurs methodes d'obtention
AU4134000A (en) 1999-04-29 2000-11-17 Syngenta Limited Herbicide resistant plants
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
EP1362109B1 (en) 2001-01-18 2009-06-10 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Recombinant oligomeric protein complexes with enhanced immunogenic potential
CN1333370A (zh) * 2001-08-16 2002-01-30 深圳市三方圆信息技术有限公司 抗家禽病毒病的作物及其生产方法
EP3009507B1 (en) * 2002-02-13 2020-06-24 Wisconsin Alumini Research Foundation Signal for packaging of influenza virus vectors
WO2003068933A2 (en) 2002-02-14 2003-08-21 Novavax, Inc. Optimization of gene sequences of virus-like particles for expression in insect cells
NZ534881A (en) * 2002-03-19 2006-09-29 Plant Res Internat B Mammalian GnTIII expression in plants
ES2224792B1 (es) 2002-06-28 2007-02-16 Era Plantech, S.L. Produccion de peptidos y proteinas por acumulacion de cuerpos proteicos derivados de reticulos endoplasmico en plantas.
CU23202A1 (es) * 2003-01-31 2007-05-18 Ct Ingenieria Genetica Biotech ANTIGENOS RECOMBINANTES DEL VIRUS DE LA HEPATITIS A OBTENIDOS EN CéLULAS VEGETALES
CN1460718A (zh) * 2003-04-11 2003-12-10 浙江大学 表达传染性支气管炎病毒纤突蛋白的转基因马铃薯生产方法
CN100393870C (zh) * 2003-05-05 2008-06-11 波依斯汤普森植物研究所 用于制备免疫保护性组合物的载体和来源于转基因植物的细胞
NZ542933A (en) 2003-05-05 2009-08-28 Dow Agrosciences Llc Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production
US7566458B2 (en) * 2003-06-16 2009-07-28 Medimmune, Llc Influenza hemagglutinin and neuraminidase variants
US8592197B2 (en) 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
JP2007528727A (ja) * 2004-02-27 2007-10-18 ザ　ダウ　ケミカル　カンパニー 植物細胞における高効率ペプチド生産
WO2006016380A2 (en) 2004-08-13 2006-02-16 Council Of Scientific And Industrial Research A chimeric g protein based rabies vaccine
PT2374892T (pt) 2005-04-29 2018-03-29 Univ Cape Town Expressão de proteínas virais em plantas
CN100410378C (zh) 2005-05-09 2008-08-13 中国农业科学院生物技术研究所 编码禽流感血凝素的基因及其植物表达载体和应用
BRPI0613625A2 (pt) 2005-07-19 2011-01-18 Dow Global Technologies Inc vacinas da gripe recombinantes
US7871626B2 (en) 2005-08-04 2011-01-18 St. Jude Children's Research Hospital Modified influenza virus for monitoring and improving vaccine efficiency
CN101605558A (zh) 2005-08-16 2009-12-16 夏威夷生物技术公司 流感重组亚单位疫苗
TWI488968B (zh) * 2005-10-18 2015-06-21 Novavax Inc 功能性流行性感冒類病毒顆粒（ＶＬＰｓ）
JP5215865B2 (ja) 2005-11-22 2013-06-19 ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド ノロウイルス抗原およびサポウイルス抗原
JP2009526526A (ja) 2006-02-13 2009-07-23 フラウンホーファー ユーエスエー， インコーポレイテッド インフルエンザ抗原、ワクチン組成物、および関連する方法
AR060565A1 (es) 2006-04-21 2008-06-25 Dow Agrosciences Llc Vacuna para la gripe aviaria y metodos de uso
WO2007130327A2 (en) 2006-05-01 2007-11-15 Technovax, Inc. Influenza virus-like particle (vlp) compositions
WO2008054540A2 (en) 2006-05-18 2008-05-08 Pharmexa Inc. Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
US20070286873A1 (en) * 2006-05-23 2007-12-13 Williams John V Recombinant Influenza H5 Hemagluttinin Protein And Nucleic Acid Coding Therefor
US7730950B2 (en) 2007-01-19 2010-06-08 Halliburton Energy Services, Inc. Methods for treating intervals of a subterranean formation having variable permeability
CN101918559A (zh) 2007-06-15 2010-12-15 麦迪卡格公司 修饰植物中的糖蛋白产生
KR100964462B1 (ko) 2007-07-10 2010-06-16 성균관대학교산학협력단 형질전환 식물 유래의 조류독감 바이러스 백신 및 그 제조방법
CA2615372A1 (en) * 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
BRPI0815662A2 (pt) 2007-08-20 2016-09-27 Fraunhofer Usa Inc vacinas, antígenos, composições, e métodos profilácticos e terapêuticos para gripe
PT2610345E (pt) * 2007-11-27 2016-01-11 Medicago Inc Partículas semelhantes ao vírus (vlps) da gripe recombinantes produzidas em plantas transgénicas que expressam hemaglutinina
WO2009083420A1 (en) 2007-12-28 2009-07-09 Unilever Plc Process for recovering aroma from tea
GB0800272D0 (en) 2008-01-08 2008-02-13 Plant Bioscience Ltd Protein expression systems
EA034733B1 (ru) 2008-01-21 2020-03-13 Медикаго Инк. Нуклеиновая кислота для увеличенной экспрессии гемагглютинина вируса гриппа в растении и ее применение
EP2294202B1 (en) 2008-07-08 2015-05-20 Medicago Inc. Soluble recombinant influenza antigens
CN102165062B (zh) 2008-07-18 2017-09-08 麦迪卡格公司 新的流感病毒免疫表位
JP5785080B2 (ja) 2008-08-27 2015-09-24 アリゾナ・ボード・オブ・リージェンツ・フォー・アンド・オン・ビハーフ・オブ・アリゾナ・ステイト・ユニバーシティＡｒｉｚｏｎａ Ｂｏａｒｄ Ｏｆ Ｒｅｇｅｎｔｓ Ｆｏｒ Ａｎｄ Ｏｎ Ｂｅｈａｌｆ Ｏｆ Ａｒｉｚｏｎａ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ 植物におけるワクチン及びモノクローナル抗体治療薬の高レベル迅速生産のためのｄｎａレプリコン系
US8283368B2 (en) 2008-08-29 2012-10-09 The Regents Of The University Of Michigan Selective ligands for the dopamine 3 (D3) receptor and methods of using the same
WO2010077712A1 (en) 2008-12-09 2010-07-08 Novavax, Inc. Bovine respiratory syncytial virus virus-like particle (vlps)
JP5871796B2 (ja) * 2009-06-24 2016-03-01 メディカゴ インコーポレイテッド ヘマグルチニンを含むキメラインフルエンザウイルス様粒子
WO2011011390A1 (en) 2009-07-20 2011-01-27 Novavax, Inc. Purified recombinant influenza virus ha proteins
ES2662778T3 (es) 2009-09-22 2018-04-09 Medicago Inc. Método de preparación de proteínas derivadas de plantas
WO2011102900A1 (en) 2010-02-18 2011-08-25 Technovax, Inc. Universal virus-like particle (vlp) influenza vaccines
JP6025214B2 (ja) 2010-11-04 2016-11-16 メディカゴ インコーポレイテッド 植物発現系
RS56157B1 (sr) 2010-11-05 2017-11-30 Novavax Inc Glikoproteinske čestice nalik virusu (vlp) besnila
TWI526539B (zh) 2010-12-22 2016-03-21 苜蓿股份有限公司 植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp

Similar Documents

Publication Publication Date Title
JP2010533001A5 (enExample)
Vahdat et al. Hepatitis B core-based virus-like particles: A platform for vaccine development in plants
WO2009050390A3 (fr) Procede de production du virus de la grippe
Hemmati et al. Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2
MY161965A (en) New influenza virus immunizing epitope
EP3199545A3 (en) Computationally optimized broadly reactive antigens for h1n1 influenza
WO2010003225A8 (en) Influenza virus-like particles (vlps) comprising hemagglutinin
RU2015146097A (ru) Получение вирусоподобных частиц вируса гриппа в растениях
JP2011182797A5 (enExample)
HRP20171213T1 (hr) Glikoproteinske čestice nalik virusu (vlp) bjesnoće
WO2010148511A8 (en) Chimeric influenza virus-like particles comprising hemagglutinin
TN2009000557A1 (en) Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant
JP2010533737A5 (enExample)
WO2009076778A8 (en) Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
MX394097B (es) Producción de partículas similares a virus en plantas.
RU2014116371A (ru) Повышение выхода вирусоподобных частиц в растениях
CN104232594B (zh) 重组类禽型h1n1流感病毒灭活疫苗株(js40/pr8)及其制备方法和应用
RU2013154698A (ru) Получение вирусоподобной частицы вируса бешенства в растениях
WO2008085147A3 (en) Novel plant virus particles and methods of inactivation thereof
MX2014000753A (es) Procedimiento para producir antigeno viral y vacunas.
JP2009225809A5 (enExample)
EP2261364A3 (en) Chloroplasts engineered to express pharmaceutical proteins
US20120171230A1 (en) Oral vaccines produced and administered using edible micro-organism
WO2006045532A3 (en) Virosome particles comprising antigens from influenza virus and hepatitis b virus
CN104711291B (zh) 一种预防禽流感病毒感染的新型血凝素抗原的制备及应用